her excitement at the prospect of work-
ing with an Israeli client to develop new
equipment that will enable researchers to
examine the tear film of those suffering
from dry eyes.
The science-business combo can yield
unique challenges too. “We’re a very inno-
vative company, but we’re operating as an
innovative company within a highly regu-
lated space,” Dr. Salapatek said.
Naturally, these regulations are not with-
out reason. Researchers are conducting
tests on live subjects and this demands
safe practices and a strict amount of scru-
tiny, but heavy regulation can sometimes
hinder productivity and progress. Over-
coming this difficulty simply entails dem-
onstrating the utility of the company’s in-
novative solutions to regulators.
The company’s plan is to continue produc-
ing cutting-edge research and expanding
into the peripheries of the market, all the
while distinguishing itself as a Canadian-
born innovation.
“We’re avery innovative company, butwe’re operatingas an innovative company
within a highly regulated space.”
MAY 2016
H
business elite canada 65
